Novartis Typhoid Vaccine Seeks Partner After Securing Pakistan Clinical Trial Site
This article was originally published in PharmAsia News
Executive Summary
Phase II study is ongoing in Pakistan, a year after Novartis convinced the Pakistani government to lift its ban on clinical trials. Antimalarials with a different mechanism of action than Coartem are in Phase I and II trials.